Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.

International journal of immunopathology and pharmacology - 1 Jan 2000

Zhang Peng, Du Wei, Yang Ting, Zhao Lei, Xiong Richeng, Li Yongqiang, Geng Yan, Lu Weizhong, Zhou Juan

Abstract excerpt

BACKGROUND: Coronavirus disease 2019 (COVID-19) had become a worldwide health threat. Early prediction of the severity of COVID-19 patients was important for reducing death rate and controlling this disease. METHODS AND MATERIALS: A total of 301 patients confirmed with COVID-19 in Wuhan from 8 February to 10 April 2020 were included. Clinical data were collected and analyzed. Diagnostic and prognostic utility of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD4 Lymphocyte Count
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hospital Mortality

Share to Host-Pathogen Interactions

Share to Lymphocyte Subsets

Share to Predictive Value of Tests

Share to SARS-CoV-2

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 34619994
DOI: 10.1177/20587384211048567
PMCID: PMC8504275

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.PMID 34619994Read ↗

Lymphocyte Count is a Universal Predictor to the Health Status and Outcomes of Patients with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Regression AnalysisSemantic proximity Read ↗

Lymphocyte count is a universal predictor to the health status and outcomes of patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-regression analysisSemantic proximity Read ↗

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective studySemantic proximity Read ↗

Implications of Laboratory Tests in Disease Grading and Death Risk-Stratification of COVID-19: A Retrospective Study in Wuhan, ChinaSemantic proximity Read ↗

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patientsSemantic proximity Read ↗

Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID-19 patients with pre-existing co-morbiditiesSemantic proximity Read ↗

Platelet-to-lymphocyte ratio (PLR), a novel biomarker to predict the severity of COVID-19 patients: a systematic review and meta-analysisSemantic proximity Read ↗

Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admissionSemantic proximity Read ↗

Analysis of Clinical Characteristics of Patients with Critical COVID-19Semantic proximity Read ↗

Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, ChinaSemantic proximity Read ↗

T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019Semantic proximity Read ↗

Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.